MAR vs NOW: Which Is the Better Buy?

Side-by-side comparison of Marriott International, Inc. and ServiceNow, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-17.
Marriott International, Inc. Β· Consumer Cyclical
$334.97
+20.6% upside to fair value
Med Conviction Grade C
VS
ServiceNow, Inc. Β· Technology
$139.82
+16.2% upside to fair value
Med Conviction Grade A- High Quality
QuantHub Verdict
MAR has more upside to fair value (+20.6%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MAR NOW
Current Price $334.97 $139.82
Fair Value Estimate $403.81 $162.50
Upside to Fair Value +20.6% +16.2%
Market Cap $87.3B $144.6B
Forward P/E β€” β€”
EV / EBITDA 22.2x 43.1x
Price / Sales 3.2x 9.8x
Price / FCF 28.7x 31.5x
Revenue Growth YoY +4.8% +24.0%
Gross Margin 20.2% 74.8%
Operating Margin 15.8% 11.4%
Return on Equity -66.7% 13.8%
Dividend Yield 0.84% 0%
FCF Yield 3.48% 3.17%
Analyst Consensus Hold Strong Buy
Investment Thesis
MAR β€” Marriott International, Inc.
Marriott International is a global asset-light hotel franchisor and manager whose 10,082-property, 1.814 million-room system, 629,000-room development pipeline, broad brands, and more than 295 million Bonvoy members support durable fee-led economics. Business quality is tempered by cyclicality, competitive owner incentives, and $16.915 billion of debt, while reported ROE is negative 66.7%. In the…
NOW β€” ServiceNow, Inc.
ServiceNow provides a cloud-based enterprise workflow platform spanning IT service management, operations, employee workflows, CRM, AI orchestration and security. Business quality is high because its common data model, deeply embedded workflows and cross-department deployments create meaningful switching costs, while roughly 90% of the Fortune 500 use the platform and more than 85 billion workflo…
Accumulation Zones
Metric MAR NOW
Zone Low $302.86 $121.88
Zone High $343.24 $138.12
In Buy Zone? Yes No
← MAR Research    NOW Research β†’    All Research